The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice
Open accessAbstract
Apolipoprotein E4 (apoE4) is the major genetic risk factor for Alzheimer's disease. However, the underlying mechanisms are unclear. We found that female apoE4 knock-in (KI) mice had an age-dependent decrease in hilar GABAergic interneurons that correlated with the extent of learning and memory deficits, as determined in the Morris water maze, in aged mice. Treating apoE4-KI mice with daily peritoneal injections of the GABA A receptor potentiator pentobarbital at 20 mg/kg for 4 weeks rescued the learning and memory deficits. In neurotoxic apoE4 fragment transgenic mice, hilar GABAergic interneuron loss was even more pronounced and also correlated with the extent of learning and memory deficits. Neurodegeneration and tauopathy occurred earliest in hilar interneurons in apoE4 fragment transgenic mice; eliminating endogenous Tau prevented hilar GABAergic interneuron loss and the learning and memory deficits. The GABA A receptor antagonist picrotoxin abolished this rescue, while pentobarbital rescued learning deficits in the presence of endogenous Tau. Thus, apoE4 causes age- and Tau-dependent impairment of hilar GABAergic interneurons, leading to learning and memory deficits in mice. Consequently, reducing Tau and enhancing GABA signaling are potential strategies to treat or prevent apoE4-related Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It exacerbates AD-related pathologies, including amyloid-beta (Aβ) plaques, Tau tangles, neurodegeneration and neuroinflammation4–16.”
From The APOE-R136S mutation protects against APOE4-driven tau pathology, neurodegeneration, and neuroinflammation (2023) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies with mouse (Andrews-Zwilling et al., 2010) and hiPSC-based (Wang et al., 2018) systems have shown that APOE genotypes might influence GABAergic interneuron generation and survival.”
From Isogenic human stem cell models reveal mutation-dependent protective mechanisms of APOE3 Christchurch (2026) · cites this paper as Andrews-Zwilling et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“apoE4 knock-in (KI) mice exhibit an age-dependent loss of hilar GABAergic interneurons and deficits in learning and memory, which is more profound when the mice express neurotoxic apoE fragments”
From ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease (2022) · cites this paper as Andrews-Zwilling et al 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tau is believed to play a key role in APOE4-related neuronal alterations during aging, as APOE4 leads to age- and Tau-dependent impairment of hilar GABAergic interneurons, resulting in learning and memory deficits in mice [75].”
The cited source says what the claim attributes to it.
In the citing paper
“and is associated with spatial learning and memory impairments [22].”
From Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development (2012) · cites this paper as [22]
In the citing paper
“For example, both apoE4 transgenic and apoE4-KI mice show age- and sex-dependent learning and memory deficits in the absence of Aβ accumulation, as compared to apoE3 transgenic and apoE3-KI mice [68–71].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [71]
In the citing paper
“In particular, GABAergic interneurons in the dentate gyrus (DG) are particularly vulnerable to apoE4 fragment-mediated neurotoxicity, and in apoE4 fragment transgenic mice, knocking out tau rescues GABAergic interneuron loss as well as learning and memory deficits, demonstrating the tau-dependent nature of apoE4-induced cognitive impairment [71].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [71]
In the citing paper
“For example, apoE4-KI mice display an age- and tau-dependent decrease in hilar GABAergic somatostatin-positive interneurons in the hippocampus [71].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
Distinct patterns of brain activity in young carriers of the APOE -ε4 allele
Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., & Mackay, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811879106 · Cited by 1,613
Cited by
Sorted by citations
Items 201–300 of 326
He, J.-W., Rabiller, G., Nishijima, Y., Akamatsu, Y., Khateeb, K., Yazdan-Shahmorad, A., & Liu, J. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19877889 · Cited by 21
Martel, G., Simon, A., Nocera, S., Kalainathan, S., Pidoux, L., Blum, D. L., Leclère-Turbant, S., Díaz, J., Gény, D., Moyse, E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.033 · Cited by 21
Pillai, J. A., Bena, J., Bonner‐Jackson, A., & Leverenz, J. B. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00771-1 · Cited by 20
Pathological changes of brain oscillations following ischemic stroke
Satō, Y., Schmitt, O., Ip, Z., Rabiller, G., Omodaka, S., Tominaga, T., Yazdan-Shahmorad, A., & Liu, J. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221105677 · Cited by 23
Sleep: The Tip of the Iceberg in the Bidirectional Link Between Alzheimer's Disease and Epilepsy
Szabo, A. B., Cretin, B., Gérard, F., Curot, J., Barbeau, E. J., Pariente, J., Dahan, L., & Valton, L. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.836292 · Cited by 21
Traumatic Brain Injury, Sleep, and Melatonin—Intrinsic Changes with Therapeutic Potential
Bell, A., Hewins, B., Bishop, C., Fortin, A. H., Wang, J., Creamer, J. L., Collen, J. F., & Werner, J. K. (2023) · Clocks & Sleep · doi:10.3390/clockssleep5020016 · Cited by 19
Retinal dysfunction in APOE4 knock‐in mouse model of Alzheimer's disease
Abhyankar, S. D., Luo, Q., Hartman, G. D., Mahajan, N. S., Corson, T. W., Oblak, A. L., Lamb, B. T., & Bhatwadekar, A. D. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14433 · Cited by 16
A New Use for an Old Treatment: Radiation Therapy and Alzheimer's Disease
Wilson, G. D., & Marples, B. (2016) · Radiation Research · doi:10.1667/rr14367.1 · Cited by 17
ApoE4 attenuates cortical neuronal activity in young behaving apoE4 rats
Har-Paz, I., Arieli, E., & Moran, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105373 · Cited by 14
Tan, X. L., Zheng, P., Wright, D. K., Sun, M., Brady, R. D., Liu, S., McDonald, S. J., Mychasiuk, R., Cenap, S., Jones, N. C., et al. (2019) · Brain Injury · doi:10.1080/02699052.2019.1667539 · Cited by 16
Receptory somatostatynowe w mózgu
Kossut, M. M., Łukomska, A., Dobrzański, G., & Liguz‐Lecznar, M. (2018) · Postępy Biochemii · doi:10.18388/pb.2018_133 · Cited by 14
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status
Marizzoni, M., Ferrari, C., Babiloni, C., Albani, D., Barkhof, F., Cavaliere, L., Didic, M., Forloni, G., Fusco, F., Galluzzi, S., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.019 · Cited by 15
A Comprehensive Analysis Identified Hub Genes and Associated Drugs in Alzheimer’s Disease
Jing, Q., Zhang, H., Sun, X., Xu, Y., Cao, S., Fang, Y., Zhao, X., & Li, C. (2021) · BioMed Research International · doi:10.1155/2021/8893553 · Cited by 15
Xu, K., Zhang, Y., Wang, Y., Ling, P., Xie, X., Jiang, C., Zhang, Z., & Lian, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101077 · Cited by 15
Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease
Juvenal, G. D. A., Higa, G. S. V., Marques, L. B., Zampieri, T. T., Viana, F. J. C., Britto, L. R. G., Tang, Y. C., Illés, P., Virgilio, F. D., Ulrich, H., et al. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10034-x · Cited by 16
Nagarajan, R., Lyu, J., Kambali, M., Wang, M., Courtney, C. D., Christian, C. A., & Rudolph, U. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03586-3 · Cited by 13
Ganesh, A., Choudhury, W., & Coutellier, L. D. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149122 · Cited by 13
Alfaro‐Ruiz, R., Aguado, C., Martín‐Belmonte, A., Moreno‐Martínez, A. E., Merchán‐Rubira, J., Hernández, F., Ávila, J., Fukazawa, Y., & Luján, R. (2022) · Brain Pathology · doi:10.1111/bpa.13115 · Cited by 14
Zaldua, S., Damen, F. C., Pisharody, R., Thomas, R., Fan, K. D., Ekkurthi, G. K., Scheinman, S. B., Alahmadi, S., Marottoli, F. M., Alford, S. T., et al. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03919 · Cited by 13
Waveform-based classification of dentate spikes
Santiago, R. M. M., Lopes‐dos‐Santos, V., Jones, E. A. A., Huang, Y., Dupret, D., & Tort, A. B. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-53075-3 · Cited by 14
Self-citationCognitive deficits in human ApoE4 knock-in mice: A systematic review and meta-analysis
van Heuvelen, M. J. G., van der Lei, M. B., Alferink, P. M., Roemers, P., & van der Zee, E. A. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115123 · Cited by 14
Tousley, A. R., Yeh, P. W. L., & Yeh, H. H. (2022) · Alcohol · doi:10.1016/j.alcohol.2022.08.003 · Cited by 13
Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model
Davies, C., Tulloch, J., Yip, E., Currie, L., Colom‐Cadena, M., Wegmann, S., Hyman, B. T., Wilkins, L., Hooley, M., Tzioras, M., et al. (2023) · Brain and Neuroscience Advances · doi:10.1177/23982128231191046 · Cited by 11
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting
Sandoval, K. E., & WITT, K. A. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001117 · Cited by 14
Genetic Discoveries in AD Using CSF Amyloid and Tau
Cruchaga, C., Ebbert, M., & Kauwe, J. S. K. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0031-0 · Cited by 11
Disease Burden Affects Aging Brain Function
Beason‐Held, L. L., Fournier, D. I., Shafer, A. T., Fabbri, E., An, Y., Huang, C.-W., Bilgel, M., Wong, D. F., Ferrucci, L., & Resnick, S. M. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab218 · Cited by 11
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis
Canosa, A., Pagani, M., Brunetti, M., Barberis, M., Iazzolino, B., Ilardi, A., Cammarosano, S., Manera, U., Moglia, C., Calvo, A., et al. (2018) · European Journal of Neurology · doi:10.1111/ene.13812 · Cited by 11
Yesiltepe, M., Yin, T., Tambini, M., Bao, H., Pan, M., d’Abramo, C., Giliberto, L., Han, X., & D’Adamio, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01832-2 · Cited by 10
“Tau is believed to play a key role in APOE4 -related neuronal alterations during aging, as APOE4 leads to age-and Tau-dependent impairment of hilar GABAergic interneurons, resulting in learning and memory deficits in mice [75].”
BackgroundMemel, M., Staffaroni, A. M., Cobigo, Y., Casaletto, K. B., Fonseca, C. S., Bettcher, B. M., Yassa, M. A., Elahi, F. M., Wolf, A. A., Rosen, H. J., et al. (2021) · Hippocampus · doi:10.1002/hipo.23327 · Cited by 12
Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele
Ji, X., Peng, X., Tang, H., Pan, H., Wang, W. D., Wu, J., Chen, J., & Wei, N. (2023) · Brain Pathology · doi:10.1111/bpa.13208 · Cited by 9
Shigapova, R. R., & Mukhamedshina, Y. O. (2024) · Life · doi:10.3390/life14060737 · Cited by 10
The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
Rosal, A. E., Martin, S. L., & Strafella, A. P. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1515374 · Cited by 10
Tabuena, D. R., Jang, S.-S., Grone, B. P., Yip, O., Jones, E. A. A., Blumenfeld, J. R., Liang, Z., Mann, R. S., Li, Y., Necula, D., et al. (2026) · Nature Aging · doi:10.1038/s43587-026-01096-0 · Cited by 17
Self-citationLyu, J., Nagarajan, R., Kambali, M., Wang, M., & Rudolph, U. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad134 · Cited by 9
Associations between Serum Tau, Neurological Outcome, and Cognition following Traumatic Brain Injury
Zheng, P., Ni, P., Qiao, Y., Tong, W., & Zhao, C. (2020) · Neurology India · doi:10.4103/0028-3886.284380 · Cited by 10
Early brainstem [18F]THK5351 uptake is linked to cortical hyperexcitability in healthy aging
Egroo, M. V., Chylinski, D., Narbutas, J., Besson, G., Muto, V., Schmidt, C., Marzoli, D., Cardone, P., Vandeleene, N., Grignard, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142514 · Cited by 13
Diaz, J. R., Martá-Ariza, M., Khodadadi‐Jamayran, A., Heguy, A., Tsirigos, A., Pankiewicz, J. E., Sullivan, P. M., & Sadowski, M. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.845291 · Cited by 11
Dammer, E. B., Shantaraman, A., Ping, L., Duong, D. M., Gerasimov, E. S., Ravindran, S. P., Guðmundsdóttir, V., Frick, E. A., Gómez, G., Walker, K. A., et al. (2023) · medRxiv · doi:10.1101/2023.10.29.23297651 · Cited by 10
The effect of β‐amyloid positivity on cerebral metabolism in cognitively normal seniors
Bozoki, A., Zdanukiewicz, M., Zhu, D. C., & Initiative, A. D. N. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.003 · Cited by 9
Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein
Kang, S., Kim, S., Noh, H. R., Kim, B. J., Kim, J.-B., Jin, U., Park, S. A., & Park, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158311 · Cited by 10
Strell, P., Johnson, S. T., Carchi, C., & Low, W. C. (2023) · Cell Transplantation · doi:10.1177/09636897231164712 · Cited by 10
Klein, R. C., Saini, S., Risher, M., Acheson, S. K., Fleming, R. L., Sexton, H. G., Swartzwelder, H. S., & Moore, S. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094071 · Cited by 8
The Adult Neurogenesis Theory of Alzheimer’s Disease
Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11
GABAergic signaling abnormalities in a novel CLU mutation Alzheimer's disease mouse model
Chen, C., Tang, X., Lan, Z., Wan, C., Su, H., Li, W., Li, Y., Zhou, X. W., Gao, H., Feng, X., et al. (2023) · Translational research · doi:10.1016/j.trsl.2023.05.003 · Cited by 8
Gray matter gamma‐hydroxy‐butyric acid and glutamate reflect beta‐amyloid burden at old age
Schreiner, S. J., Bergen, J. M. G. V., Gietl, A. F., Buck, A., Höck, C., Pruessmann, K. P., Henning, A., & Unschuld, P. G. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12587 · Cited by 8
Lu, S., Qiu, S., Yu, G., Zhang, A., & Zhao, Q. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103097 · Cited by 8
Perez, S. M., Boley, A. M., McCoy, A. M., & Lodge, D. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087196 · Cited by 6
Mechanismen der Alzheimer-Krankheit
Busche, M. A., Staufenbiel, M., Willem, M., Haass, C., & Förstl, H. (2016) · Der Nervenarzt · doi:10.1007/s00115-015-0041-5 · Cited by 7
Electrophysiological insights into Alzheimer's disease: A review of human and animal studies
Calvin, K., McNeela, A. M., Osse, A. M. L., Bhasin, G., Ridenour, M., Kinney, J. W., & Hyman, J. M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105987 · Cited by 8
Unleashing the potential: 40 Hz multisensory stimulation therapy for cognitive impairment
Chen, X., Lv, Z., Xie, G., Zhao, C., Zhou, Y., Fu, F., Li, J., Zhang, X., Qi, F., Xu, Y., et al. (2025) · Journal of Central Nervous System Disease · doi:10.1177/11795735251328029 · Cited by 9
Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele
Roberts, R. O., Aakre, J. A., Cha, R. H., Kremers, W. K., Mielke, M. M., Velgos, S. N., Geda, Y. E., Knopman, D. S., & Petersen, R. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00172 · Cited by 6
Apolipoprotein E and Amyloid-β-Independent Mechanisms in Alzheimer’s Disease
Kanekiyo, T., & Bu, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00006-1 · Cited by 6
A Review on Current Strategies and Future Perspective in Respect to Alzheimer’s Disease Treatment
Bais, S., Kumari, R., & Prashar, Y. (2015) · Current Research in Neuroscience · doi:10.3923/crn.2016.1.15 · Cited by 6
Cerebral amyloid angiopathy-related cardiac injury: Focus on cardiac cell death
Xu, X., Xu, H., & Zhang, Z. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1156970 · Cited by 6
Too Much Tau in Interneurons Impairs Adult Hippocampal Neurogenesis in Alzheimer’s Disease
Najm, R., Rao, A. T., & Huang, Y. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.02.004 · Cited by 5
Self-citationAltered lipid metabolic homeostasis in the pathogenesis of Alzheimer’s disease
Marian, O. C., Tran, C., & Don, A. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00023-3 · Cited by 5
Korada, S., Tam, O. H., Greco, H. C., Hammell, M., Dubnau, J., & Sher, R. B. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1012007 · Cited by 6
Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies
Tripathi, S., Sharma, Y., & Kumar, D. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037326839241014054430 · Cited by 5
Zhang, H., Liu, Q., Sun, X., Xu, Y., Fang, Y., Cao, S., Niu, B., & Li, C. (2021) · Current Bioinformatics · doi:10.2174/1574893617666211220154326 · Cited by 4
Futácsi, A., Rusznák, K., Szarka, G., Völgyi, B., Wiborg, O., & Czéh, B. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1542229 · Cited by 4
Seizures and Epilepsy in Dementia: Diagnosis and Management
Ritter, L. M., & Nilsson, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-77904-7_12 · Cited by 4
Kang, D. W., Wang, S., Um, Y. H., Kim, N.-Y., Lee, C. U., & Lim, H. K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.871323 · Cited by 4
Labuza, A., Pidikiti, H., Alldred, M. J., Ibrahim, K. W., Peng, K. Y., Pasato, J., Heguy, A., Mathews, P. M., & Ginsberg, S. D. (2025) · Brain Sciences · doi:10.3390/brainsci15101117 · Cited by 4
He, Q., Jiang, L. H., Chao, F., Zhou, C., Zhang, L., Zhou, Y., Wang, Y., Deng, Y., Tang, J., Luo, Y., et al. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115319 · Cited by 4
Takeda, K., Yamaguchi, Y., Hino, M., & Kato, F. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229021 · Cited by 3
Jones, E. A. A., Gillespie, A. K., Yoon, S. Y., Frank, L. M., & Huang, Y. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3362352 · Cited by 3
Self-citationSomatostatin and the pathophysiology of Alzheimer’s diseasePreprint
Almeida, V. N. (2023) · Qeios · doi:10.32388/goy6dk · Cited by 2
Hippocampal Interneurons Shape Spatial Coding Alterations in Neurological Disorders
Ikebara, J. M., Jorge, R. S., Marinho, L. S. R., Higa, G. S. V., Adhikari, A., Reis, F. M., Borges, F. S., Ulrich, H., Takada, S. H., Pasquale, R. D., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05020-2 · Cited by 3
Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone
Schurman, C. A., Kaur, G., Kaya, S., Bons, J., Aguirre, C. G., Liu, Q., King, C. D., Wilson, K. A., Baker, H., Hady, M., et al. (2026) · Advanced Science · doi:10.1002/advs.202523511 · Cited by 2
Salehinejad, M. A., & Jouzdani, A. F. (2026) · Brain Network Disorders · doi:10.1016/j.bnd.2026.01.002 · Cited by 2
Kang, D. W., Wang, S., Um, Y. H., Kim, N. Y., Lee, C. U., & Lim, H. K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220427 · Cited by 2
Costigan, A. G., Umla‐Runge, K., Evans, J., Raybould, R., Graham, K. S., & Lawrence, A. D. (2021) · Neuroimage Reports · doi:10.1016/j.ynirp.2021.100059 · Cited by 2
Korada, S., Tam, O. H., Greco, H. C., Hammell, M., Dubnau, J., & Sher, R. B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.06.658329 · Cited by 2
Mahley, R. W. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_2-1 · Cited by 1
APOE ε4 carriage is associated with olfactory-hippocampal tract functional connectivity
Ikuta, T., Bither, T., & Initiative, T. A. D. N. (2026) · Brain Imaging and Behavior · doi:10.1007/s11682-026-01109-x · Cited by 1
Cell-type-specific APOE4 cascade across the Alzheimer’s disease continuum
Shostak, D. M., Liang, Z., & Huang, Y. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.024 · Cited by 1
Self-citationCardona, E. A., Webber, C. J., Wu, Z., Bolton, B., Cenik, E. S., & Pierce-Shimomura, J. T. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052469 · Cited by 1
Sendrowski, K., & Sobaniec, W. (2015) · Journal of Epileptology · doi:10.1515/joepi-2015-0035 · Cited by 1
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
Craig, G. E., Ramos, L., Essig, S. R., Eagles, N. J., Jaffe, A. E., Martinowich, K., & Hallock, H. L. (2024) · eNeuro · doi:10.1523/eneuro.0328-24.2024 · Cited by 1
Apolipoprotein E ε4-Specific Relationship Between Serum Olfactomedin 4 and Alzheimer’s Disease
Wei, C., Zhang, G., Fu, X., Zhao, M. L., Zhai, W., Shen, Y., & Sun, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04812-w · Cited by 1
Dentate gyrus neurogenesis across different ages in male rats: an immunohistochemical approach
Ghallab, A. M., Alazouny, Z. M., Samak, M. A., & Malek, H. G. A. (2019) · Biologia · doi:10.2478/s11756-019-00246-7 · Cited by 1
Epilepsy genetics—considerations for clinical practice today and for the future
Goldman, A. M., & Noebels, J. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00017-5 · Cited by 1
Approaching Alzheimer’s disease from a network level
Gillespie, A. K., Jones, E. A. A., & Huang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.14617 · Cited by 1
Self-citationJones, E. A. A., Gillespie, A. K., Yoon, S. Y., Frank, L. M., & Huang, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/596569 · Cited by 1
Self-citation(outdated draft) Somatostatin and the pathophysiology of Alzheimer’s diseasePreprint
Almeida, V. N. (2024) · Qeios · doi:10.32388/goy6dk.2
Craig, G. E., Ramos, L., Essig, S. R., Eagles, N. J., Jaffe, A. E., Martinowich, K., & Hallock, H. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.22.604695 · Cited by 1
Frisch, C., Baker, L., Srinivasan, G., Mintah, A. E., Leyasi, S., Pedroza, M., Galyon, B., & Brafman, D. A. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1856154
Heaney, C. F. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/7645911
Abad‐Rodríguez, J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.002
Albrecht, M. A., & Foster, J. K. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_7
The Proteolysis of Apolipoprotein E in Alzheimer's Disease
Love, J. E. (2016) · ScholarWorks (Boise State University)
Saeed, U. (2018) · TSpace (University of Toronto)
Winslow, M. (2019) · ScholarWorks (Boise State University) · doi:10.18122/td/1567/boisestate
Amyloid beta: from pre-analytical factors to disease mechanisms
Toombs, J. (2019) · UCL Discovery (University College London)
Epilepsy genetics in clinical practice today and for the future
Goldman, A. M., & Noebels, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00033-9 · Cited by 1
Insights into the Pathogenesis of Alzheimer’s Disease for Better Therapeutics
Agrawal, A., & Purushothaman, S. S. (2024) · Premier journal of science. · doi:10.70389/pjs.100042
Cardona, E. A., Webber, C. J., Wu, Z., Bolton, B. M., Cenik, E. S., & Pierce, J. T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.06.652574
Epigenetic effects of Nosustrophine in Alzheimer’s disease
Martínez-Iglesias, O. A., Naidoo, V., Carrera, I., Corzo, L., & Cacabelos, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00024-4
Metadata
- Authors
- Andrews-Zwilling, Y., Bien-Ly, N., Xu, Q., Li, G., Bernardo, A., Yoon, S. Y., Zwilling, D., Yan, T. X., Chen, L., & Huang, Y.
- Affiliations
- University of California, San Francisco (US)
- Gladstone Institutes (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-10-13
- Volume
- 30
- Issue
- 41
- Pages
- 13707-13717
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2988475
- OpenAlex
- W1977434686
- Cited by
- 326
- References
- 66
- Citations by year
- 2026: 20 · 2025: 17 · 2024: 24 · 2023: 22 · 2022: 20 · 2021: 27 · 2020: 26 · 2019: 23 · 2018: 9 · 2017: 20 · 2016: 29 · 2015: 14 · 2014: 24 · 2013: 20 · 2012: 21
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Gladstone Institutes
- National Institutes of Health (1c06rr018928-01, AG‐022074)
- National Institute on Aging (P01AG022074)
- National Center for Research Resources (C06RR18928, C06-RR-018928)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- APOE ε4, Alzheimer's disease, GABAergic interneurons, hilar interneurons, tauopathy, learning and memory impairment, GABAA receptor, pentobarbital, picrotoxin, neurodegeneration, hippocampus, aging
- MeSH terms
- Age Factors, Analysis of Variance, Animals, Cells, Cultured, Electrophysiology, Female, gamma-Aminobutyric Acid, Immunohistochemistry, Interneurons, Memory Disorders, Mice, Transgenic, Nerve Degeneration, Pentobarbital, tau Proteins, Presynaptic Terminals, Statistics, Nonparametric, Maze Learning, Dentate Gyrus, Mice, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
